Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00650780 · ClinicalTrials.gov registry record
Vitamin D Binding Protein (Gc) Allele Variation Effects Response to Vitamin D Treatment
A clinical trial, sponsored by Creighton University.
- Completed
- Registry status
- 29
- Enrollment target
NCT00650780 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 29 participants.
The verdict
NCT00650780 has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
We have just completed a randomized, clinical trial of 100,000 IU Vitamin D3 given as a single dose at the beginning of winter. We found a wide range of responses to the dose. This study proposes that genetic differences account for some of the variation in response of 25(OH)D levels after treatment with oral Vitamin D.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00650780
The ClinicalTrials.gov registry entry for NCT00650780 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00650780 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00650780 about?
NCT00650780 is a clinical study titled "Vitamin D Binding Protein (Gc) Allele Variation Effects Response to Vitamin D Treatment". We have just completed a randomized, clinical trial of 100,000 IU Vitamin D3 given as a single dose at the beginning of winter. We found a wide range of responses to the dose. This study proposes that genetic differences account for some of the variation in response of 25(OH)D levels after treatment...
What is the current status of trial NCT00650780?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2007-10. Estimated completion is 2008-01.
Who is sponsoring clinical trial NCT00650780?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.